Zynex Investors Face Class Action Lawsuit Over Alleged Misleading Statements

Multiple law firms have filed or announced class action lawsuits against Zynex, Inc. on behalf of investors who purchased the company's securities between March 13, 2023 and March 11, 2025, alleging that Zynex engaged in deceptive business practices. The lawsuits claim that Zynex shipped products, such as electrodes, in excess of need to inflate revenue and filed false claims, actions which drew scrutiny from insurers including Tricare, the U.S. military health insurance program. These practices allegedly led to Zynex being removed from certain insurer networks and facing penalties, with the company later reporting a significant revenue shortfall and a suspension of payments from Tricare. Notably, the company's stock price dropped sharply following media reports of these practices and the subsequent financial disclosures. Investors are encouraged to consider joining the class action before the May 19, 2025 lead plaintiff deadline to potentially recover losses. The lawsuits argue that Zynex's positive statements about its business and financial health during the relevant period were materially misleading or lacked a reasonable basis.